A new collaboration between the Department of Energy's Pacific Northwest National Laboratory and the Air Force's 59th Medical Wing hopes to improve on drug tests for illicit drug use and abuse. Not only are the researchers looking for a better indicator of current or past use, but they'd like to be able to identify people prone to abusing drugs in the first place.
Funded by the Department of Defense, the $850,000 two-year study will lay the foundation for future work to determine who might be susceptible to hydrocodone. Initially, the collaboration will map out drug breakdown products, proteins and other compounds that healthy bodies make in response to the prescription painkiller hydrocodone.
"We want to enhance the prevention, diagnosis and treatment of drug addiction. Our military deserves the best care we can give them," said Lt. Col. (Dr.) Vikhyat Bebarta, a research physician in the 59th Medical Wing at Lackland Air Force Base near San Antonio, Texas. Bebarta will be co-leading the study with biochemist Josh Adkins of PNNL.
The results will likely extend beyond the military. "Any tools for drug addiction that come out of this study could also be used by the general public," said Adkins.
Just as some genes confer a susceptibility to alcoholism, the team hopes to find some indicator of susceptibility to dependence on painkillers such as hydrocodone. Instead of a gene, though, the researchers hope to find a difference in how a susceptible person responds to the drug, compared to a nonsusceptible one. If such an indicator exists in blood, urine or saliva, not only would it improve our understanding of the biological response to hydrocodone, but tests that reveal the indicator could be developed.
The painkiller hydrocodone is one of the most abused drugs in the U.S. Its use, abuse and addictive potential pose special concern for the armed forces, whose members suffer trauma more often than the average civilian. Hydrocodone is an opioid closely related to the opiate morphine. Both military and civilian doctors are prescribing hydrocodone more often, making it more accessible for people to misuse and abuse.
The rising prescription rate and greater availability has likely contributed to an increase in number of patients in treatment. Admission for drug abuse treatment programs for hydrocodone and related opiates more than quadrupled between 1997 and 2007, according to a 2007 report from the National Admissions to Substance Abuse Treatment Services. (This does not include the opiate heroin, which remained stable over that time.)
Knowing if a military member is misusing or abusing hydrocodone is essential to national security and to the safety of military personnel. In 2005, the Department of Defense found that 7.3% of active duty personnel across all branches of the military had used analgesics including hydrocodone without a medical need in the previous year.
Doctors have several tests to determine who is using hydrocodone or other illicit drugs, but they are inadequate. The simplest -- a screening questionnaire -- is not definitive. And current blood or urine tests for hydrocodone only determine whether the drug been used in the last few hours or days. In addition, several drugs cross react in the blood test, making them unreliable.
More important, there is no current screening test for recent or past hydrocodone use. Psychotherapeutics rank right behind marijuana as the most commonly abused drugs among the military and civilians, and hydrocodone and other pain relievers are the most popular of the psychotherapeutics.
To determine if someone had been using hydrocodone in the recent past, the researchers will take snapshots of changes that can be detected in blood or urine. "We already know how it works in the brain, so we will focus on the body. Hydrocodone has a physiological response on the whole body to fight pain," said Bebarta.
The first part of the study seeks to determine the baseline for what hydrocodone does to normal healthy subjects. The researchers will look for changes to a variety of body systems after healthy volunteers take the drug. The systems they're looking at include the pain response, inflammation, and stress -- all known to be involved in hydrocodone's effect.
"Partnering with the 59th Medical Wing takes advantage of the strengths in each group," said PNNL biologist Karin Rodland, chief scientist for biomedical research and co-investigator on the team.
Because the Air Force researchers have extensive expertise in toxicology and drug metabolism at Wilford Hall Medical Center in San Antonio, they will perform the part of the study that looks at how hydrocodone gets metabolized. Backed by PNNL's expertise in the field of proteomics, the PNNL team will check for changes in about 2000 different protein levels using state-of-the-art instruments in EMSL, DOE's Environmental Molecular Sciences Laboratory on the PNNL campus.
The baseline studies will take two to three years to complete. Armed with a baseline, the researchers will be able to conduct other experiments with hydrocodone-dependent patients to look for indicators that identify those who are most likely to abuse it.
Eventually, the team's goal is for a clear understanding of a dependent patient's complete physiological response to opioids. They are hopeful they will find a susceptibility marker and discover new ways to personalize opioid pain medicine. "That would require a systems biology level of understanding of a person's response to opiate," said Rodland, "but we hope we get the chance to try."
EMSL, the Environmental Molecular Sciences Laboratory located at Pacific Northwest National Laboratory, is a national scientific user facility sponsored by the Department of Energy's Office of Science, Biological and Environmental Research program. EMSL offers an open, collaborative environment for scientific discovery to researchers around the world. EMSL’s technical experts and suite of custom and advanced instruments are unmatched. Its integrated computational and experimental capabilities enable researchers to realize fundamental scientific insights and create new technologies.EMSL's Facebook page.
Pacific Northwest National Laboratory is a Department of Energy Office of Science national laboratory where interdisciplinary teams advance science and technology and deliver solutions to America's most intractable problems in energy, national security and the environment. PNNL employs 4,700 staff, has an annual budget of nearly $1.1 billion, and has been managed by Ohio-based Battelle since the lab's inception in 1965. Follow PNNL on Facebook, LinkedIn and Twitter.
Mary Beckman | Newswise Science News
Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University
New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg
Satellites in near-Earth orbit are at risk due to the steady increase in space debris. But their mission in the areas of telecommunications, navigation or weather forecasts is essential for society. Fraunhofer FHR therefore develops radar-based systems which allow the detection, tracking and cataloging of even the smallest particles of debris. Satellite operators who have access to our data are in a better position to plan evasive maneuvers and prevent destructive collisions. From April, 25-29 2018, Fraunhofer FHR and its partners will exhibit the complementary radar systems TIRA and GESTRA as well as the latest radar techniques for space observation across three stands at the ILA Berlin.
The "traffic situation" in space is very tense: the Earth is currently being orbited not only by countless satellites but also by a large volume of space...
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.
The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
23.03.2018 | Event News
19.03.2018 | Event News
16.03.2018 | Event News
23.03.2018 | Materials Sciences
23.03.2018 | Agricultural and Forestry Science
23.03.2018 | Physics and Astronomy